Shigeru Hasebe

Assistant professor

Setsunan University
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (8)

Year:

2026

Year:

2026

Year:

2026

Objectives This study aimed to disentangle the independent effects of aging and cumulative antiretroviral therapy (ART) duration on polypharmacy in people with HIV. While successful ART has led to an aging population with HIV, polypharmacy may stem from both aging and ART's cumulaftive toxicity. Quantitative evidence separating these effects is scarce, particularly in Japan. Methods In this retrospective study, we analysed a Japanese community pharmacy database (2014–2022) of 696 people on ART for ≥6 months. Using negative binomial regression, we assessed the independent effects of age and cumulative ART duration on the number of concomitant medications (a proxy for polypharmacy), adjusting for sex. Results Both advanced age and cumulative ART duration were significant independent risk factors for polypharmacy. A strong dose‐dependent relationship was observed with age (incidence rate ratio [IRR] for 60–69 years: 9.61; 95% confidence interval [CI], 4.92–18.78 vs. <30 years). After adjusting for age and sex, a cumulative ART duration of ≥9 years remained an independent predictor of more concomitant medications (IRR: 1.81; 95% CI, 1.05–3.13 vs. <1 year). Conclusions We propose a “dual‐structure model” for polypharmacy in people with HIV, comprising age‐related multimorbidity and a distinct layer potentially linked to the long‐term effects of ART. To our knowledge, this study provides the first quantitative evidence from Japan to statistically disentangle the associations with these two factors. Our findings highlight the need to integrate geriatric principles with HIV‐specific toxicity management for optimal long‐term strategies.

Year:

2025

Antiretroviral therapy (ART) has dramatically improved outcomes for people living with HIV (PLWH), yet concerns about cardiovascular disease (CVD) remain, especially in aging populations. In this study, we aimed to evaluate the association between ART regimens and CVD events in Japan using a nationwide pharmacovigilance database. We retrospectively analyzed reports from the Japanese Adverse Drug Event Report Database spanning April 2004 to September 2024. After removing duplicates and records with key missing data, 796,402 reports (Population A) were used for signal detection based on the reporting odds ratio (ROR) and information component (IC). A refined subset (Population B; 2,721 reports) underwent logistic regression to identify risk factors for major adverse cardiovascular events (MACE) and total cardiovascular events (MACE plus angina). ART regimen classes (e.g., integrase strand transfer inhibitors, non-nucleoside reverse transcriptase inhibitors, and protease inhibitors) and backbone therapies [e.g., abacavir (ABC)/lamivudine] were included in the analysis. Signal detection revealed significant ABC signals in both ROR and IC analyses for MACE and total CVD events. In logistic regression, advanced age (≥70 years), ABC-containing regimens, and diabetes emerged as independent risk factors for MACE and total CVD events. Dyslipidemia and hypertension were not significant in the adjusted models. Our findings underscore a potentially heightened cardiovascular risk associated with ABC, particularly in older PLWH or those with diabetes. These results highlight the need to consider individual CVD risk profiles when selecting ART regimens and reinforce the importance of ongoing pharmacovigilance to guide safer, more personalized treatment strategies worldwide.

Year:

2025

Background Dispensing errors associated with “same-name drugs” and “similar-name drugs” are common, negatively affecting patients. Using two pairs of error-induction models, this study analyzed pharmacists' gaze movements while dispensing by an eye-tracking method to interpret their thought processes. Thus, we aimed to assess the efficiency and safety of dispensing processes by examining right-brain function using error-induction models. Methods We created verification slides for display on a prescription monitor and three drug rack monitors. The prescription monitor displayed the dispensing information, including drug name, drug usage, location display, and total amount. A total of 180 drugs, including five target drugs, were displayed on the three-drug rack monitors. We measured total gaze points in the prescription area (Gaze 1), total gaze points in the drug rack area (Gaze 2), total vertical eye movements between the two areas (Passage), time required to dispense drugs (Time), and the error rate for each verification (Error). First, we defined two types of location display methods: “numeral combination” and “color/symbol combination”. Then, we established two pairs of error-induction models, F 1 -F 2 (same-name drugs) and G 1 -G 2 (similar-name drugs), to compare the differences between the two location display methods in the designated area. Results Significant differences in gaze movements of pharmacists between the models F 1 -F 2 were observed in Gaze 2, Passage, and Time (F 1 > F 2 , P G 2 , P G 2 , P = 0.020), but not between the models F 1 -F 2 ( P = 0.286). Conclusions Incorporating visual information into prescription content not only performs a series of dispensing tasks more smoothly, but also reduces the error occurrences by pharmacists. In other words, leveraging right-brain utilization in dispensing processes has led to improvements in both efficiency and safety.

Year:

2025

Year:

2024

Background Pharmacists should be aware of their thought processes in dispensing work, including differences in the dispensing complexities owing to different drug positions in the left, center, and right areas. Dispensing errors associated with “same-name drugs (a pair of drugs with the same name but a different ingredient quantity)” are prevalent and often negatively affect patients. In this study, using five pairs of comparative models, the gaze movements of pharmacists in dispensing work were analyzed using an eye-tracking method to elucidate their thought processes. Methods We prepared verification slides and displayed them on a prescription monitor and three drug rack monitors. The dispensing information (drug name, drug usage, location display, and total amount) was displayed on a prescription monitor. A total of 180 drugs including five target drugs were displayed on the three drug rack monitors. Total gaze points in the prescription area, those in the drug rack area, total vertical movements between the two areas, and time required to dispense drugs were measured as the four classifications Gaze 1, Gaze 2, Passage, and Time, respectively. First, we defined the two types of location displays as “numeral combination” and “color/symbol combination.” Next, we defined two pairs of models A 1 -A 2 (numerals) and B 1 -B 2 (color/symbol) to compare differences between the left and right areas. Moreover, three pairs of models C 1 -C 2 (left), D 1 -D 2 (center), and E 1 -E 2 (right) were established to compare differences between “numeral combination” and “color/symbol combination.” Results Significant differences in the complexities of dispensing work were observed in Gaze 2, Passage, and Time between the models A 1 -A 2 (A 1 B 2 ), and in Gaze 2 and Time between the models C 1 -C 2 , D 1 -D 2 , and E 1 -E 2 (C 1 >C 2 , D 1 >D 2 , and E 1 >E 2 , respectively). Conclusions Using the current dispensing rules, pharmacists are not good at dispensing drugs located in the right area. An effective measure for reducing the dispensing complexity is to introduce visual information in the prescription content; the utilization of the right brain facilitates reducing the complexity in the right dispensing area.

Year:

2024

Collaborators (4)

Rei Yokoyama

Assistant Professor

Hiroshima University

JAPAN
View details

Masayuki Tanaka

Setsunan University

JAPAN
View details

Takeshi Hirota

Professor

Nagasaki University

JAPAN
View details

Naoya Oishi

准教授 / Associate Professor

Kyoto University

JAPAN
View details